Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2019, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2019-11-20
DOI
10.1155/2019/7676909
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer
- (2018) Harvey J. Murff et al. CANCER CAUSES & CONTROL
- Anti-cancer effects of metformin: recent evidences for its role in prevention and treatment of cancer
- (2018) Masoumeh Kheirandish et al. CURRENT DRUG METABOLISM
- Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
- (2016) Gadi Shlomai et al. JOURNAL OF CLINICAL ONCOLOGY
- No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK
- (2015) Bernd Kowall et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Association between Five Lifestyle Habits and Cancer Risk: Results from the E3N Cohort
- (2014) L. Dartois et al. Cancer Prevention Research
- Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
- (2014) Konstantinos K. Tsilidis et al. DIABETES CARE
- The Early Treatment of Type 2 Diabetes
- (2013) Richard E. Pratley AMERICAN JOURNAL OF MEDICINE
- Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
- (2013) Craig J. Currie et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
- (2013) Bindiya Thakkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Latest insights into the risk of cancer in diabetes
- (2013) Hiroshi Noto et al. Journal of Diabetes Investigation
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus
- (2012) H. Qiu et al. DIABETES OBESITY & METABOLISM
- The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
- (2012) Ming-Chia Hsieh et al. Experimental Diabetes Research
- Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study
- (2011) R. Ruiter et al. DIABETES CARE
- Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry
- (2010) Xilin Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes
- (2010) Ebenezer A. Nyenwe et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Diabetes and cancer
- (2009) Paolo Vigneri et al. ENDOCRINE-RELATED CANCER
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More